Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06321627
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-03-13
Brief Title:
Radiosensitivity of HPV-related Tumors Towards a Genomic Approach
Sponsor:
European Institute of Oncology
Organization:
European Institute of Oncology
Study Overview
Official Title:
Radiosensitivity of HPV-related Tumors Towards a Genomic Approach - ICARUS Project
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ICARUS
Brief Summary:
The purpose of this study is therefore to analyze the genomic profiles of prognosis and radiosensitivity of Human Papilloma Virus HPV related tumors from different body sites oropharynx uterine cervix and anus considering them as a unified entity regardless of the site of origin within the body
Detailed Description:
The present study ICARUS - genomIC RAdiosensitivity viRUS involves the collection of data retrospective and prospective from an extensive cohort of patients with HPV-related tumors of the oropharynx cervix and anus
The aim is to
1 investigate the role of Cl2 in non-oropharyngeal HPV-related tumors and
2 compare the Radiation Sensitivity Index RSI values of HPV-related tumors in patients who responded to radiotherapy responders with those of patients with radioresistant tumors non-responders
The aim is to
1 investigate the role of Cl2 in non-oropharyngeal HPV-related tumors and
2 compare the Radiation Sensitivity Index RSI values of HPV-related tumors in patients who responded to radiotherapy responders with those of patients with radioresistant tumors non-responders
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None